chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Initial report was received from a healthcare professional on 29 August 2013. A 49-year-old female patient had received an intramuscular injection in the left deltoid of ADACEL (lot number C4432AB) on 27 August 2013 at 14:50 PM. The patient had Td vaccine in 1994. This was the first time with Tdap. The patient left the clinic without symptoms. The patient did not feel well "during the evening" (onset date reported as 28 August 2013). 911 was called and the patient was taken to the emergency room (ER). The ER reported anaphylaxis and gave the patient epinephrine. The patient was discharged and went home and was doing well. The patient had no illness at the time of vaccination but did have a toe injury. The patient had no allergies and no health problems. The reporter was getting information third hand. She had no further description of the symptoms. The patient's outcome was recovered. Documents held by sender: None.
shortness of breath; bad headaches; chest pain; rash on his neck and behind his ears; This is a spontaneous report from a contactable consumer (patient).  A 57-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number N5318), via an unspecified route of administration on 27Jan2021 as single dose for covid-19 immunization.  The patient's medical history and concomitant medications were not reported.  The patient experienced shortness of breath, bad headaches, chest pain and rash on his neck and behind his ears, all on  an unspecified date in 2021.  The events were all serious as they involved hospitalization from 02Feb2021 to 03Feb2021. Details were as follows: patient received the first dose of the vaccine on 27Jan2021;  he had a lot of bad side effects and  went to the hospital: shortness of breath, bad headaches, chest pain, rash on his neck and behind his ears. All  this happened a few days after receiving the vaccine. He had an appointment with his cardiologist and he will have a cardiac catheter placed on 19Feb2021. The second dose of the vaccine was scheduled for 18Feb2021. The outcome of the events were unknown.
First shot gave me vertigo; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-May-2021 and was forwarded to Moderna on 27-May-2021.    Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (First shot gave me vertigo) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (First shot gave me vertigo). At the time of the report, VERTIGO (First shot gave me vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided.  Treatment medications was not provided.   Reporter did not allow further contact
Shingles; This case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced shingles. On an unknown date, the outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 24-Aug-2022 Reporters comments: The patient self-reported this case via interactive digital media. The patient received shingles vaccine and still got shingles. The doctor said the patient must've had a mild dose, 2 years prior to being vaccinated, declined receiving another dose. Additional supportive information: The follow-up would not possible, as no contact, details were available.
Post vax, the pt complained of her arm being warm and itchy at injection site. The next day it started to sting with slight warmth to the touch. Advised if condition becomes worse to contact her doctor. For the present, she was advised to apply ice and take and analgesic.
Two days after the injection of the Moderna I saw a small irritated area on both my ankles.  It appeared about sock high and I imagined it was just a rub and maybe I tightened my boots a bit too much.  The next day it was a nasty looking dark red rash that looked like it had broken the skin but had not.  It didn't itch, there was no pain and it darkened after my shower, so I scheduled a clinic visit.  It was worse the next day and migrating upwards.  The migrated red was more like dots, small and moved up the sides of my legs to my hips and shoulders, both sides evenly, but not nearly as bad as the original outbreak at my ankles which worsened.  I saw dr.  and he suggested Benadry, took pictures and conferred with a collegue.  I bought Benadryl, took one tablet.  That night I took two Tylenol PM.  In the morning the rash was still spreading upward, but was less dark and still no pain or itchiness.  I took 3 Benadryl throughout the day, and one Tylenol PM that night.  The rash began to fade and didn't redden as bad in the shower.  It faded more each day, but it was evident on my shoulders and hips, still nothing compared to the ankles.  I got a call from Dr. that I should not get the second Moderna Covid 19 shot and wait and possibly get the Johnson and Johnson vaccine when it's available.  I asked him what I could expect if I ignored his advice and did it anyways. ....He said, "I think I need to talk to your wife".. So there you go.
Information has been received from a physician referring to a 33 years old female patient. The patient's concurrent condition, concomitant medication and medical history were not provided. On 04-SEP-2018 the patient was vaccinated with PNEUMOVAX 23 (strength, dose, frequency, route, lot # and expiration date were not provided)for prophylaxis at arm. The patient was also vaccinated with a previous dose of PNEUMOVAX 23 in approximately 2012 (reported as an unspecified date "5-6 years ago"). On 05-SEP-2018 the patient came into the office with redness on the whole arm of administration, swelling in the right side of the upper arm of administration and the swelling almost looked like a mass. The patient was in the office at the time of the report. The outcome of the events was reported as not recovered. The causality assessment was not provided.
13 yr. old pt. given PROQUAD and Varicella vaccine. MMR was read on PROQUAD vaccine but not Varicella. "PROQUAD" Label not clearly visible on vial. Pt. was prescribed TYLENOL for possible fever.
Projectile vomiting; vertigo; nausea; body aches; extreme fatigue.
This spontaneous report as received from a nurse of unknown age reporting on herself. No information regarding the patient's pertinent medical history, concomitant medications, drug reactions or allergies was provided. On 14-JAN-2019, the patient was inadvertently vaccinated with M-M-R II (lot number and expiration date not reported), intramuscularly. No adverse effecters were reported.
Realized after the fact that vaccine had been given with 5/8 subcutaneous syringe in the deltoid.  No adverse event reported.
Left breast hurting, felt like a large lump. Went away after a few weeks. Heart and chest pains, pressure on heart, dull pain throughout the day
11x12 cm area on left deltoid that is erythematous and indurated and tender to touch. Temp up to 102.3 degree. Treated with BENADRYL and MOTRIN po.
Pfizer-BioNTech Covid-19 Vaccine EUA, 11:30 pm 4/20 thru 5am 4/22: shakes, chills, fever, body aches, joint pain, painful sensation on skin surface, confusion, need to sleep, no appetite.
This spontaneous report as received from a pharmacist refers to 2 patients of unknown age and gender. No information about medical history, concurrent conditions was reported for the patients. On an unknown date the patients were vaccinated with improperly stored ZOSTAVAX 19400 Plaque forming units (PFU) (dose strength, route unspecified). No adverse effects reported. The outcome of events reported is unknown. No product quality complaint was involved. Additional information has been requested.
Persistant, unconsolable crying w/in 2 hrs p/DTP; comfort measures to no avail; Crying lasted 3-4 hrs; Called MD resolved w/in 24 hrs;
This case was reported by a pharmacist via call center representative and described the occurrence of hives in a 72-year-old female patient who received SHINGRIX (batch number CH2X7, expiry date 25th April 2020). Concomitant products included PREMARIN cream and SYNTHROID. On 6th April 2018, the patient received the 1st dose of SHINGRIX .5 ml. On 7th April 2018, 1 days after receiving SHINGRIX, the patient experienced hives and erythematous rash. In April 2018, the patient experienced pruritus. On an unknown date, the outcome of the hives and pruritus were unchanged and the outcome of the erythematous rash was unknown. It was unknown if the reporter considered the hives, pruritus and erythematous rash to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that 1 day after receiving SHINGRIX vaccination, the patient experienced red bumps all over the chest and the back. Less than a week after receiving SHINGRIX, the patient experienced itchiness. The reporter provided information for patients health care provider. All questions were asked.
Neck pain; Flu like symptoms; Muscle aches; This case was reported by a pharmacist via call center representative and described the occurrence of influenza-like symptoms in a 56-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 16th September 2019, the patient received the 1st dose of Shingrix (intramuscular). On 17th September 2019, 1 days after receiving Shingrix, the patient experienced influenza-like symptoms and muscle pain. On 30th September 2019, the patient experienced neck pain. On an unknown date, the outcome of the influenza-like symptoms and muscle pain were recovered/resolved and the outcome of the neck pain was not recovered/not resolved.   It was unknown if the reporter considered the influenza-like symptoms, muscle pain and neck pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, however the patient could be 56 or 57 years old at time of vaccination. On 16th September 2019, the patient received his first dose of Shingrix via intramuscular route in the left deltoid.  On 17th September 2019, the patient developed flu like symptoms and muscle aches resolving spontaneously without treatment. On or about 30th September 2019, the patient developed persistent pain in neck that is reported as ongoing. The reporter did not consent to follow-up.
Sore arm at the injection site 24 hours post vaccine then symptoms  of nausea, weakness, tired, headache started 12/20/2020, 4 days post the vaccine. Went to the ER on the 12/21/20-12/22/20 due to increase headache, vomiting, diarrhea, dizzy, dry cough, weak/extremely fatigue. At the ER was given IV fluid, Zofran, Phenergan, tested for the Flu and Covid, also had blood work. All my blood work came back in normal ranges, FLU and Covid test were negative as well. Discharged from the ER with Phenergan, the next 3 days I had a migraine and had to be in a dark room with lights off, still very dizzy, tired, shortness of breath with movement, could not eat it made me nauseas. Called for follow up with PCP he then put me on steroids, for 7 days. 12/28 called PCP office again, was put on another round of steroid treatment with antibiotic. Was off work from 12/21/2020-01/02/21 due to the sickness post the vaccine
increased headache and migraine frequency, increased severity of migraines, inability to treat migraine with medication for relief, increased and worsening secondary symptoms of migraines (worse nausea, new tremors, new tachycardia, worse shortness of breath, worse light sensitivity, inability to eat due to worse nausea)
my vision was extremely blurry and lasted for probably about 15 hours; Could not move my left arm; arm where she received the injection was swollen; arm where she received the injection was sore; if she presses the area where she got injected it still has that little bit of tenderness; headache; would use her right arm to move her left arm because of the soreness; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (my vision was extremely blurry and lasted for probably about 15 hours), HYPOKINESIA (Could not move my left arm), VACCINATION SITE SWELLING (arm where she received the injection was swollen), VACCINATION SITE PAIN (arm where she received the injection was sore) and INJECTION SITE PAIN (if she presses the area where she got injected it still has that little bit of tenderness) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (my vision was extremely blurry and lasted for probably about 15 hours), HYPOKINESIA (Could not move my left arm), VACCINATION SITE SWELLING (arm where she received the injection was swollen), VACCINATION SITE PAIN (arm where she received the injection was sore), INJECTION SITE PAIN (if she presses the area where she got injected it still has that little bit of tenderness), HEADACHE (headache) and MYALGIA (would use her right arm to move her left arm because of the soreness). At the time of the report, VISION BLURRED (my vision was extremely blurry and lasted for probably about 15 hours), HYPOKINESIA (Could not move my left arm), VACCINATION SITE SWELLING (arm where she received the injection was swollen), VACCINATION SITE PAIN (arm where she received the injection was sore), INJECTION SITE PAIN (if she presses the area where she got injected it still has that little bit of tenderness), HEADACHE (headache) and MYALGIA (would use her right arm to move her left arm because of the soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD21-071310 (Linked Report).; Sender's Comments:  MOD21-071310:crosslink
Given the vaccine on day 31 days of expiry; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Given the vaccine on day 31 days of expiry) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A and 046C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Oct-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Oct-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Given the vaccine on day 31 days of expiry). On 14-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Given the vaccine on day 31 days of expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were mentioned. No treatment details were reported.   This case was linked to MOD-2021-353224, MOD-2021-353228, MOD-2021-353252, MOD-2021-353261, MOD-2021-353569, MOD-2021-353578, MOD-2021-353593, MOD-2021-353262, MOD-2021-353249 (Patient Link).
Three days after second vaccination developed red, itchy rash covering  large portion of outer upper arm,. Was swollen. Also, diarrhea that day. Later in day of shot was fatigued, during night chills and severe muscle aches. Aches and low fever the next day.
Information has been received from a health professional concerning a 15 year old female who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck).  Concomitant therapy included a dose of BCG vaccine and a dose of Hepatitis B vaccine, recomb (manufacturer unknown).  Subsequently, the patient felt faint and passed out for under a minute.  The patient woke up and felt a little sluggish, but is now recovered.  Unspecified medical attention was sought.  No product quality complaint was involved.  No additional information was provided.  Additional information has been requested.
titers were low; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of therapeutic response decreased in a patient who received HBV (Engerix B adult) for prophylaxis.   On an unknown date, the patient received Engerix B adult. On an unknown date, an unknown time after receiving Engerix B adult, the patient experienced therapeutic response decreased (Verbatim: titers were low).  The outcome of the therapeutic response decreased was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 23-AUG-2023 The reporter mentioned the Adult patient received their Engerix dose last year (2022) but the patient's titers were low, this was why the physician recommended a higher dose Engerix. The reporter stated that the physician would like to administer a Engerix high dose of 40 mcg but the HCP has 20 mcg of Engerix on hand and how to proceed. It was Engerix vaccine dose has not been administered yet to the patient. The reporter declined to provide patient details. The reporter did not consent to follow up.
On April 13, I experienced a fever of 102.5 and chills, that went up and down until I went to the emergency room at Hospital on April 16, and was diagnosed with bacterial pneumonia. I was prescribed a 7 day treatment of Lexofloxacin 500 mg. I had no fever  after day 3 of treatment. As of this date, I have a  very low energy/stamina level.
SORE ARM WHEN SOMEONE PRESSES  ON IT; NAUSEA; DULL HEADACHE; This spontaneous report received from a patient concerned a 43 year old female. The patient's height, and weight were not reported. The patient's past medical history included loss of sense of taste, loss of sense of smell, nausea, dull headache, and covid-19 infection. The patient was previously treated with influenza vaccine virosomal for product use for unknown indication.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 206A21A and expiry: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 10-DEC-2020, Laboratory data included: COVID-19 PCR test (NR: not provided) Positive. On APR-2021, the subject experienced sore arm when someone presses on it.  On APR-2021, the subject experienced nausea. On APR-2021, the subject experienced dull headache. Treatment medications (dates unspecified) included: ibuprofen, and oxycodone/paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm when someone presses on it, nausea, and dull headache on 09-APR-2021. This report was non-serious.
Tightness of chest same night. Developed into shortness of breath, cough, and restricted airways. High blood pressure, fast pulse, easy bruising. Breathing issues are still ongoing, treating with steroid and rescue inhalers. Patient was not using inhalers at all prior to the vaccine.
Around 6pm of 03/25/21 I started to feel a sore arm and stiffening of my shoulders and neck. 7pm I took my first dose of 2 - 500mg Tylenol. 7:30pm body chills kicked in and were persistent through out the night along with headache. (Second dose of Tylenol was 12am 2 - 650mg)  Around 9pm I started to feel nauseous, it wasn?t til about 2am 03/26/21 I woke up from my sleep to vomit & my body muscles were all in pain I didn?t even have the strength to move. I took my temperature before I laid back down which was 101.1. Woke up 3/26/21 at about 8am (took 3rd dose of Tylenol 2-650mg) with a consistent headache, muscle pain , and nausea. Temperature has lowered 98.7 but body chills have started again. Also I have no appetite.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 56-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 06May2022 as dose 4 (booster), single (Lot number: FM9992) at the age of 56 years, in left arm for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Dose Number: 1, Batch/Lot No: ER8730, Location of injection: Arm Left), administration date: 25Mar2021, when the patient was 55-year-old, for COVID-19 immunization; BNT162b2 (DOSE 2, SINGLE, Dose Number: 2, Batch/Lot No: EW0158, Location of injection: Arm Left), administration date: 15Apr2021, when the patient was 55-year-old, for Covid-19 immunization; BNT162b2 (DOSE 3 (BOOSTER), SINGLE, Dose Number: 3, Batch/Lot No: EW0178, Location of injection: Arm Left), administration date: 11Nov2021, when the patient was 56-year-old, for COVID-19 immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 06May2022, outcome "not recovered", described as "Swelling in lymph nodes in neck". Therapeutic measures were not taken as a result of lymphadenopathy. Additional information: No other vaccine in four weeks. Prior to the vaccine patient did not have covid and post vaccination covid tested was unknown.
Large area of induration and erythema on right thigh where received DTaP and HEP A 2 days prior.  No systemic symptoms.
About 10minutes post vaccine, he started c/o tingling to the right side of his neck and radiating down to his fingers. Vital signs were stable: BP 129/87, 97% RA, temp 97, HR 75, respirations 20, denies pain.  Also c/o sweating palms, nausea but no emesis, mild dizziness, no SOB/difficulty breathing. Stated he did not eat anything this morning. Provided with crackers and water.  At 0839, re-evaluated, nausea improved VS 132/88, hr 73, 98% RA, denies pain, continues to have tingling but not worsening, sweaty palms improving.  At 0905 tingling and nausea have improved no longer c/o dizziness, vs 130/95, hr 81, 98% RA, RR 18, denies pain. Felt good to go home.  Total time of about 30 minutes wait.
I received the first Pfizer vaccine t 2:45 PM on Thursday, 2/25/21. That night when I went to bed I felt chilled and woke up several times feeling chilled.  In the morning I felt sick with similar symptoms as when I had COVID-19 in March2020. I had head pains, inner ear pains, naseau, sore muscles, and extreme fatigue. I slept the whole day, waking up and going back to sleep. I dranka little, but just didn't feel like it. I ate a piece of toast with butter that evening and then felt naseauated.  I slept through the night and woke up feeling a little better the next day, but still feel tired and have some pains in my head.
A couple days after receiving a Tdap vaccine the patient developed an outbreak of shingles. He developed a rash on his side and a slight fever. Rash was not at injection site. The rash was sensitive to touch and on the left side of his chest. There was some blistering and it was hard for the patient to take deep breaths. The patient was prescribed Valcyclovir 1000mg TID for 10 days to treat the rash.